The Weekly Roundup: January 22-26

Guselkumab Significantly Clears Scalp Psoriasis in Patients With Skin of Color in Phase 3b VISIBLE

The VISIBLE clinical program will create a longitudinal collection of more than 20,000 clinical images across all skin tones.

Prenatal Exposure to Opioids Linked to Increased Odds of Eczema and Dermatitis

In a recent study, prenatal opioid exposure was also linked to increased odds of infections and asthma, but not with allergies, anaphylaxis, or autoimmune conditions.

Roflumilast Foam, 0.3% for Seborrheic Dermatitis Launches in US

Zoryve was approved for the treatment of seborrheic dermatitis in patients ages 9 years and older in December.

Clinician Confidence and Diagnostic Accuracy Significantly Improves With Support of Artificial Intelligence in Melanoma Detection

Researchers also found that explainable AI methods, also known as XAI, further contributed to the confidence and accuracy associated with AI assistance.

Reviewing Camouflage Techniques in Black Women With Alopecia and Hair Loss

A recent review evaluated the role of camouflage and concealment techniques and their role in improving the well-being of Black women with hair loss.

Maral Kibarian Skelsey, MD, Shares Insights Into DermTech’s 2-GEP Assay Success

DermTech’s study results demonstrated that in patients with Fitzpatrick skin types IV-VI, all 3 melanomas diagnosed by histopathology were correctly identified by the 2-GEP assay as positive for LINC00518 and PRAME.

Study: Injectable Poly-L-lactic Acid Treatments Effective for Cheek Wrinkles

Subjects who received Sculptra treatments reported improvement in skin radiance and firmness.

Caregivers and Patients With Atopic Dermatitis Prioritize Symptom Control, Adverse Effect Management

A study explored the prioritization habits of both patients with atopic dermatitis and their caregivers when it comes to treatment.

Dermatology Clinicians Prefer Topical Corticosteroids in Pediatric Patients With Alopecia Areata, Study Finds

Among dermatologists specializing in pediatric alopecia areata, a survey found that class 1 and 2 topical corticosteroids are the preferred first-line therapy.

LEO Pharma Completes Key Asset Acquisition, Including TMB-001, From Timber Pharmaceuticals

The finalized acquisition comes 5 months after Timber Pharmaceuticals filed for chapter 11 bankruptcy.

Photoprotective Awareness, Behaviors Lacking Among Lebanese Population

Approximately half of patients presenting to dermatology clinics in Beirut reported the use of sunscreen.

Melanoma Overdiagnosis Rising Among White Patients

89% of white men and 85% of white women who received a diagnosis of melanoma in 2018 were likely overdiagnosed, according to a new study.

Jordan Miller, MD: 2024 Dermatology Predictions

Advancements in assistance from artificial intelligence include ambient listening to take notes during physician and patient conversations.

POLL: Do You Utilize Artificial Intelligence When Completing Skin Checks?

Click here to answer this week's poll.

Targeted Social Media Recruitment Efficient, Effective in Trial for Low-Grade Actinic Keratosis

Online patient recruitment methods were effective in a proof-of-concept trial involving patients with low-grade AK.

The Pediatric Dermatology Research Alliance Offers Grants and Fellowships to Researchers

PeDRA has awarded more than $1.8 million to researchers, and deadlines to apply for the next round of grants are coming soon.

Dosing Starts in Phase 3 ASC40 Trial For Acne Treatment

Investigators explained how the trial is structured to inhibit facial sebum production and inflammation among nearly 500 study participants.

Tailoring AD Management Advice to Lifestyles and Hobbies

In a recent Dermatology Times Case-Based Roundtable Meeting, Tina Bhutani, MD, MAS, shared intriguing cases and insights about atopic dermatitis treatment challenges faced by patients with different lifestyles and hobbies.

Trifarotene Yields Significant Improvements in Post-Inflammatory Hyperpigmentation

A poster presented at Maui Derm Hawaii delved into the efficacy and safety of trifarotene 50µg/g cream in acne vulgaris and PIH.

Researchers Say Evidence Points to Need for Terminology Change in Axillary and Inguinal Lentiginosis in Neurofibromatosis

Researchers from Pyeongchon, Korea, argue that evidence points to the need for a change in the terminology of "freckling," according to a poster from Maui Derm Hawaii.

New Year Report Card for Dermatologists and Their Practices

This article delves into 5 critical areas that dermatologists should focus on for a comprehensive 2024 report card.

Pointers With Portela: Effective Wart Treatments

In this week’s Pointers With Portela, the 208SkinDoc reviews various treatment methods for permanent wart removal.

Patient Preferences in Atopic Dermatitis Treatment

Patients with moderate to severe AD gave their opinions in a survey on treatment options and their tradeoffs. Itch control topped the list of patient concerns.

Study Points Toward Stark Disparity of Academic Papers Referencing Sunscreen in Patients With Skin of Color

A poster from Maui Derm Hawaii revealed an even more significant disparity than researchers anticipated.

How to Handle Social Media Retaliation

A patient's social media post has gone viral and has been seen by thousands. Dr Derm is concerned this malicious act may ruin his career. What can he do?

Higher Scalp Hair Loss Linked to Noticeable Gaps or Absence in Eyebrow and Eyelash Hair in Patient Study

A poster analyzing the BRAVE-AA study population was presented at Maui Derm Hawaii 2024.

The Year Ahead in Dermatology

So far, 2024 is shaping up to be just as busy as 2023 with new dermatology innovations, approvals, and data. Review what's still to come in 2024.

Light-Responsive Drug Delivery System for Skin Cancer Holds Promise

The novel nanofiber-based system holds promise for future nanotech applications in health care, researchers claim.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.